Navigation Links
Top Heart Programs Choose Safety of Medivance's Non-Invasive Arctic Sun(R) for Therapeutic Hypothermia
Date:12/9/2008

Best hospitals adhere to trend in medicine favoring non-invasive interventions that minimize needless complications

LOUISVILLE, Colo., Dec. 9 /PRNewswire/ -- The nation's top-rated heart programs continue to favor the non-invasive, safe and technologically advanced Arctic Sun Temperature Management System from Medivance for cooling critically ill patients.

Cooling comatose cardiac arrest survivors is an evidence-based standard of care recommended by the American Heart Association.

"Therapeutic hypothermia is the single most effective intervention to improve neurologic outcome after out-of-hospital cardiac arrest," says Brian O'Neil, MD, Emergency Department Research Director at Beaumont Hospital in Royal Oak, Michigan, ranked among the nation's top 15 heart programs. "Our experience with it has been outstanding, as the data we recently presented at the American College of Emergency Physicians Research Forum and the Society of Academic Emergency Medicine meetings indicate."

The preference for the Arctic Sun is in keeping with the strong trend in medicine toward least invasive methods. Consequently, more than half of the 50 heart programs ranked best in the nation by U.S. News & World Report now use the Arctic Sun to quickly induce hypothermia and then slowly rewarm their critically ill patients. In the topmost ranks, 80 percent of the 20 top hospitals prefer the safety and precision of Medivance's non-invasive device.

"We use the Arctic Sun for two reasons. It's non-invasive, and it's extremely reliable for maintaining temperature within the narrow range required for maximum therapeutic benefit," Dr. O'Neil says.

The non-invasive Arctic Sun System avoids the unnecessary risks associated with invasive cooling catheters. And because nurses initiate the therapy, cooling
'/>"/>

SOURCE Medivance
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Mediterranean Diet Enriched With Nuts Cuts Heart Risks
2. Womens Death Rate Higher From Severe Heart Attack
3. Double threat: Deadly lung disease also linked to heart attacks
4. Study finds treatment fails to improve common form of heart failure
5. The ESC launches a new release of HeartScore
6. UCSF Medical Center Leads Nation in ER Heart Attack Care
7. Rapid Response Teams Dont Cut Hospital Heart Attacks, Death Rates
8. Light Drinking Poses No Heart Risk for Women
9. Generic Heart Drugs as Good as Brand-Name Counterparts
10. Mini heart attacks lessen damage from major ones
11. Vitamin D Vital for the Heart

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Best-Selling author and P... to discuss Organizational Transformation through ...geles, CA (PRWEB) December 4, 2009 -- IMPAQ Acco...oday that Mark Samuel , best-selling Author, ren...untability Business Consultants Inc., will present...
(Date:12/3/2009)..., , PHILADELPHIA, Dec. 3 /PRNewswire-USNew...ction today against the International Brotherhood ...y blocked vehicles from leaving the facility, inte...,, (Logo: http://www.newscom.com/cgi-bin/prnh/...ted a work stoppage against the American Red Cross...
(Date:12/3/2009)..., , WASHINGTON, Dec. 3 /PRNewswire-USNewsw...rkins responded today to the U.S. Senate,s approv...ikulski (D-MD) to authorize the Health Resources a...ion as "preventive care" in their guidelines. If H... then all group and individual health plans will b...
(Date:12/3/2009)..., , MINNEAPOLIS, Dec. 3 Ch...en named a recipient of the 2009 Leapfrog Top Hosp...zed for delivering care that is among the best in ... of efficiency. ,, The Leapfrog survey is the o...y issues including mortality rates for common proc...
(Date:12/3/2009)..., , CHICAGO, Dec. 3 /PRNewswire-USNewswire...ced today that the United States District Court fo...eliminary approval of the previously disclosed $35...tion lawsuit against UnitedHealth Group. ,, The... State of New York and Missouri State Medical Asso...
Breaking Medicine News(10 mins):Health News:Mark Samuel, CEO & Founder, IMPAQ Accountability Business Consultants Inc., to Present at 14th ICF Annual International Conference 2Health News:American Red Cross Wins Court Injunction Against Striking Teamsters 2Health News:Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 2Health News:Children's Hospitals and Clinics of Minnesota Receives National Recognition for Quality and Efficiency 2Health News:Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 2
...ers kick butts, SAN DIEGO, Jan. 21 RealAge.com, ... is launching a new program to guide and,support n...08., RealAge,s new Stop Smoking Center launched t... Young and other,best-selling YOU books. The Cleve...
...s product line and distri... Orthopedics, Inc., an,emerging medical device com... replacement, trauma and tissue regeneration surgi...g will be used,primarily to expand the current pro...
...have a different appearance than other irregular s... a report in the January issue of Archives of Derm...es of malignant melanoma continue to increase, and...ore common in individuals with many moles or other...
...ance on cold medications, study says , , M...special saline nasal wash made from Atlantic seawa...lu, and may prevent recurrence of these infections...-author Dr. Jana Skoupa, of Pharma Projects in Pra...
...ion of,FLAVORx, Inc., which distributes a veterina...y, the nation,s largest compounding pharmacy, have... veterinarians to make pet,medications taste good.... The process is quick, easy and,cost-effective and...
...ge of,Occupational and Environmental Medicine (ACO...ce-based practice guidelines. The chapter on low b...cupational Medicine Practice,Guidelines: Evaluatio... to UMK Professional (Utilization Management Knowl...
Other Medicine News:Health News:RealAge Challenges and Cheers Smoke-Free Wannabes in 2008 2Health News:Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO 2Health News:Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO 3Health News:Melanomas may appear noticeably different than other moles 2Health News:Saline Nasal Wash Helps Kids Fight Colds, Flu 2Health News:Saline Nasal Wash Helps Kids Fight Colds, Flu 3Health News:FLAVORx Teams up with Wedgewood Pharmacy to Make it Even Easier to Make Pet Medications Taste Good 2Health News:FLAVORx Teams up with Wedgewood Pharmacy to Make it Even Easier to Make Pet Medications Taste Good 3Health News:Low Back Disorders Chapter Released 2
(Date:12/3/2009)....C., Dec. 3 In response...nformation technologies in the evolving healthcare...ke Center for Health Informatics (DCHI) to provide...oversee an innovative interdisciplinary approach t...physicians, nurses and healthcare administrators w...
(Date:12/3/2009)...O, Dec. 3 Cardium Therap... wholly-owned subsidiary, Tissue Repair Company, s...th the U.S. Food and Drug Administration (FDA) see...roduct candidate based on positive data from the C...al study. Today,s submission with the FDA covers ...
(Date:12/3/2009)...inn., Dec. 3 Apnex Medical, Inc., ...t has completed a second round of private equity f...sed to complete a clinical study and develop a sec...nology designed to treat obstructive sleep apnea (...Domain Associates, New Enterprise Associates (NEA)...
Breaking Medicine Technology:Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Apnex Medical, Inc. Raises Additional $14 Million 2Apnex Medical, Inc. Raises Additional $14 Million 3This Fathers Day Give Dad a Gift Straight for the Heart 49181 1This Fathers Day Give Dad a Gift Straight for the Heart 49181 2This Fathers Day Give Dad a Gift Straight for the Heart 49181 3URAC Stresses Importance of Standards for Wellness Programs and Health Plan at AHIP Institute 2009 49179 1URAC Stresses Importance of Standards for Wellness Programs and Health Plan at AHIP Institute 2009 49179 2URAC Stresses Importance of Standards for Wellness Programs and Health Plan at AHIP Institute 2009 49179 3China Biotics Inc to Join Russell 3000 Index 12669 1China Biotics Inc to Join Russell 3000 Index 12669 2China Biotics Inc to Join Russell 3000 Index 12669 3
... Volunteers to be Presented at ...harmaceuticals,Inc. (Nasdaq: ANDS ) announced tod... of ANA598 in healthy volunteers and finalization ...patients chronically infected,with hepatitis C vir...as,well tolerated at all doses analyzed to date an...
...ASE: BIOV) from Rehovot, Israel, reported today re...vasive diagnostic test under development for,early...of 76 sputum samples were collected from four,grou...er smoked 2. Heavy smokers with no signs of lung ... 1) 4. Advanced stage lung cancer patients, The ...
Other Medicine Technology:Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 2Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 3Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 4Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 5Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 6BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test 2
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: